NCT05099068 Profiling Program of Cancer Patients With Sequential Tumor and Liquid Biopsies (PLANET) Status UNKNOWN Phase NA
NCT05095441 A Clinical Study of Intratumoral MVR-C5252 (C5252) in Patients With Recurrent or Progressive Glioblastoma Status NOT_YET_RECRUITING Phase PHASE1
NCT05095376 Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05076513 Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma Status ACTIVE_NOT_RECRUITING Phase EARLY_PHASE1
NCT05074992 A Trial of Neoadjuvant Therapy in Patients With Newly Diagnosed Glioblastoma Status TERMINATED Phase PHASE2
NCT05063682 The Efficacy and Safety of Brain-targeting Immune Cells (EGFRvIII-CAR T Cells) in Treating Patients With Leptomeningeal Disease From Glioblastoma. Administering Patients EGFRvIII -CAR T Cells May Help to Recognize and Destroy Brain Tumor Cells in Patients Status UNKNOWN Phase PHASE1
NCT05054400 Study of Laser Interstitial Thermal Therapy (LITT) Treatment Response Assessment With Fluciclovine PET MR Status WITHDRAWN Phase EARLY_PHASE1
NCT05039346 Quality of Life and Patient Needs in Advanced High Grade Gliomas Status COMPLETED Phase N/A
NCT05015543 Physical Training in Glioblastoma Patients During Cytotoxic Therapy Status COMPLETED Phase NA
NCT04998864 Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption in GBM Patients Status COMPLETED Phase N/A
NCT04982926 A Study of TAS2940 in Participants With Locally Advanced or Metastatic Solid Tumor Cancer Status TERMINATED Phase PHASE1
NCT04974983 Impact of Bevacizumab on Symptom Burden and Neurological Deficits in Patients With Recurrent Glioblastoma Status COMPLETED Phase N/A
NCT04970615 Educating Brain Tumor Patients Using Patient-specific Actual-size Three-dimensional Printed Models Status UNKNOWN Phase N/A
NCT04963413 RENEW: Feasibility of CMV RNA-Pulsed Dendritic Cells Vaccines for the Treatment of Newly Diagnosed Glioblastoma Patients. Status TERMINATED Phase PHASE1
NCT04937413 The PCSK9i Inhibitor Evolocumab - a Surgical Trial of Pharamcodynamics and Kinetics Evaluation Status COMPLETED Phase EARLY_PHASE1
NCT04933422 CM93 Treatment in Subjects With Epidermal Growth Factor Receptor (EGFR)-Modified Recurrent Glioblastoma (rGBM) Status NOT_YET_RECRUITING Phase PHASE1
NCT04922723 Radiation/Temozolomide and Immunotherapy With Daratumumab to Improve Antitumor Efficacy in Glioblastoma Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04913337 Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2